{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:59:16Z","timestamp":1793908756701,"version":"4.8.0"},"reference-count":75,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T00:00:00Z","timestamp":1188518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:p>The emergence of multiresistant bacterial strains and the continuing burden of infectious disease globally point to the urgent need for novel affordable antimicrobial drugs. Thioridazine is a phenothiazine antipsychotic drug with well\u2010recognized antimicrobial activity, but this property has not been harnessed for clinical use as a result of its central nervous system and cardiac side\u2010effects. The cardiotoxicity of thioridazine has recently been shown to be structurally specific at a molecular level, whereas its antimicrobial properties are shared by a number of phenothiazine analogues. This raises the possibility that its enantiomers or its inactive metabolite, the ring sulphoxide, may act as a lead compound in the future development of antimicrobial drugs to face the new challenges in infectious disease.<\/jats:p>","DOI":"10.1111\/j.1365-2125.2007.03021.x","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T07:12:09Z","timestamp":1188976329000},"page":"566-574","source":"Crossref","is-referenced-by-count":69,"title":["Thioridazine: resurrection as an antimicrobial agent?"],"prefix":"10.1111","volume":"64","author":[{"given":"H. K. R.","family":"Thanacoody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,24]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/138945006777709539"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000239036"},{"key":"e_1_2_10_4_2","first-page":"259","article-title":"Clinical, biochemical and post\u2010mortem studies on a patient treated with chlorpromazine","volume":"4","author":"Forrest FM","year":"1963","journal-title":"Revue Agressologie"},{"key":"e_1_2_10_5_2","first-page":"953","article-title":"Uber die Wirkung des Methylenblau bei Malaria","volume":"39","author":"Guttman P","year":"1891","journal-title":"Berliner Klinika Wochenschrift"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100069"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104913.75206.62"},{"key":"e_1_2_10_8_2","first-page":"77","article-title":"QT interval prolongation and ventricular arrhythmias","volume":"13","author":"Thomas SHL","year":"1994","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90150-2"},{"key":"e_1_2_10_10_2","first-page":"546","article-title":"Thioridazine hydrochloride (Mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities","volume":"89","author":"Kelly HQ","year":"1963","journal-title":"CMAJ"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02035-3"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb01421.x"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.12.1161"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.180.6.515"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/003335490712200205"},{"key":"e_1_2_10_16_2","volume-title":"Global Tuberculosis Control \u2013 Surveillance, Planning, Financing.","author":"World Health Organisation.","year":"2007"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1596\/978-0-8213-6133-7"},{"key":"e_1_2_10_18_2","unstructured":"World Health Organisation.Available athttp:\/\/www.who.int\/leishmaniasis\/burden\/magnitude\/burden_magnitude\/en\/index.html(last accessed: 15 April 2007)."},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(02)00126-1"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00110-3"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(03)00205-X"},{"key":"e_1_2_10_22_2","first-page":"787","article-title":"Clinical concentrations of thioridazine enhance the killing of intracellular methicillin\u2010resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study","volume":"18","author":"Martins M","year":"2004","journal-title":"In Vivo"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.719-726.2003"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(03)00200-0"},{"key":"e_1_2_10_25_2","first-page":"361","article-title":"Thioridazine reduces resistance of methicillin\u2010resistant Staphylococcus aureus by inhibiting a reserpine\u2010sensitive efflux pump","volume":"20","author":"Kristiansen MM","year":"2006","journal-title":"In Vivo"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.823"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto960105.x"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.6.1049"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(00)00199-0"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.917-922.2003"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(00)00343-5"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1993.tb06337.x"},{"key":"e_1_2_10_33_2","first-page":"113","article-title":"In vitro activities of phenothiazine\u2010type calmodulin antagonists against Mycobacterium leprae","volume":"98","author":"Dhople AM","year":"1999","journal-title":"Microbios"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1998.tb01115.x"},{"key":"e_1_2_10_35_2","first-page":"491","article-title":"Calmodulin\u2010like activity in mycobacteria","volume":"28","author":"Salih FA","year":"1991","journal-title":"Indian J Biochem Biophys"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1992.tb05442.x"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1139\/m92-057"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500469102"},{"key":"e_1_2_10_39_2","first-page":"445","article-title":"Chemotherapeutics: scientific principles, methods, and results","author":"Ehrlich P","year":"1913","journal-title":"Lancet"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-5-84"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00804.x"},{"key":"e_1_2_10_42_2","first-page":"249","article-title":"The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo\u2010isomeric compounds cis(Z)\u2010 and trans(E)\u2010clopenthixol","volume":"93","author":"Kristiansen JE","year":"1985","journal-title":"Acta Pathol Microbiol Immunol Scand [B]"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.1.209"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2006.00391.x"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715760100300311"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/1071576021000046622"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.2174\/138945006778226615"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568006023337745"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034989957943"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2003.10.006"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.01.014"},{"key":"e_1_2_10_52_2","first-page":"733","article-title":"The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co\u2010infected AIDS patient","volume":"19","author":"Viveiros M","year":"2005","journal-title":"In Vivo"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6124040"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.5.571"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(03)00204-8"},{"key":"e_1_2_10_56_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/clpt.1991.22","article-title":"Plasma levels of thioridazine and metabolites are influenced by the debrisoquine hydroxylation phenotype","volume":"49","author":"Von Bahr C","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0576-4"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100195"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.006445"},{"key":"e_1_2_10_60_2","first-page":"334","article-title":"Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine","volume":"231","author":"Kilts CD","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_61_2","first-page":"117","article-title":"Comparative antidopaminergic properties of thioridazine, mesoridazine and sulphoridazine on the corpus striatum","volume":"250","author":"Niedzwiecki DM","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_62_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00007691-198204000-00005","article-title":"Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects","volume":"4","author":"Dahl SG","year":"1982","journal-title":"Ther Drug Monit"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(88)90006-8"},{"key":"e_1_2_10_64_2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-3565(24)38082-6","article-title":"Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current","volume":"288","author":"Drolet B","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)73083-X"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2003.10.017"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100194"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(84)90215-7"},{"key":"e_1_2_10_69_2","first-page":"100","article-title":"Thioridazine toxicity \u2013 an experimental cardiovascular study of thioridazine and its major metabolites in overdose","volume":"27","author":"Heath A","year":"1985","journal-title":"Vet Hum Toxicol"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01953235"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.020990"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.10.039"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1774"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.10.013"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm071"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/9.5.197"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2007.03021.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2007.03021.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T21:03:54Z","timestamp":1737407034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2007.03021.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,24]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1365-2125.2007.03021.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2007.03021.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,24]]}}}